Evidence map›Paper›PMID 19662022›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2009

Inhibitory effect of ETB receptor on Na(+)-K(+) ATPase activity by extracellular Ca(2+) entry and Ca(2+) release from the endoplasmic reticulum in renal proximal tubule cells.

Yan Liu, Jian Yang, Hongmei Ren, Duofen He, Annabelle Pascua, M Ines Armando, Chengming Yang, Lin Zhou, Robin A Felder, Pedro A Jose and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Effect of DCardiology discovery · 2023
    Article
  5. Article
  6. Role of GRK4 in the regulation of the renal ETB receptor in hypertension.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  7. Evidence for a regulated CaJournal of cell science · 2019
    Article
  8. Article
  9. Endothelin Blockade in Diabetic Kidney Disease.Journal of clinical medicine · 2015
    Review
  10. Endothelin and renal ion and water transport.Seminars in nephrology · 2015
    Review
  11. Article
  12. Article
  13. Article
  14. Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Yan LiuDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, PR China.
Jian Yang
Hongmei Ren
Duofen He
Annabelle Pascua
M Ines Armando
Chengming Yang
Lin Zhou
Robin A Felder
Pedro A Jose
Chunyu Zeng
Daping Hospital · CNArmy Medical University · CNGeorge Washington University · USChildren's National · USUniversity of Virginia · US

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GILDEA, JOHN JOSEPH · 2004 to 2020
$31.8M
Renal Vascular Oxidative Stress in HypertensionP01HL068686 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A., SANDBERG, KATHRYN L · 2001 to 2017
$28.8M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
Renal Dopamine Receptor & RegulationR37HL023081 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 2007 to 2016
$4.3M
GRK4 & Development of Salt SensitivityR01HL092196 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ARMANDO, INES, JOSE, PEDRO A. · 2008 to 2017
$3.6M
RENAL DOPAMINE RECEPTOR REGULATION AND FUNCTIONR01HL023081 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A. · 1985 to 2006
$2.4M
GENE MUTATIONS IN HUMAN HYPERTENSIONR01HL062211 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FELDER, ROBIN A · 1999 to 2002
$1.2M
NHLBI NIH HHS HL074940NHLBI NIH HHS HL092196NHLBI NIH HHS HL23081NHLBI NIH HHS HL62211NHLBI NIH HHS HL68686NHLBI NIH HHS P01 HL068686NHLBI NIH HHS P01 HL074940NHLBI NIH HHS R01 HL023081NHLBI NIH HHS R01 HL092196NHLBI NIH HHS R37 HL023081NIDDK NIH HHS DK39308NIDDK NIH HHS R01 DK039308
6 · The paper itself

Abstract

The kidney is important in the long-term regulation of blood pressure and sodium homeostasis. Stimulation of ETB receptors in the kidney increases sodium excretion, in part, by decreasing sodium transport in the medullary thick ascending limb of Henle and in collecting duct. However, the role of ETB receptor on Na(+)-K(+) ATPase activity in renal proximal tubule (RPT) cells is not well defined. The purpose of this study is to test the hypothesis that ETB receptor inhibits Na(+)-K(+) ATPase activity in rat RPT cells, and investigate the mechanism(s) by which such an action is produced. In RPT cells from Wistar-Kyoto rats, stimulation of ETB receptors by the ETB receptor agonist, BQ3020, decreased Na(+)-K(+) ATPase activity, determined by ATP hydrolysis (control=0.38+/-0.02, BQ3020=0.26+/-0.03, BQ788=0.40+/-0.06, BQ3020+BQ788=0.37+/-0.04, n=5, P<0.01). The ETB receptor-mediated inhibition of Na(+)-K(+) ATPase activity was dependent on an increase in intracellular calcium, because this effect was abrogated by a chelator of intracellular-free calcium (BAPTA-AM; 5 x 10(-3) M 15 min(-1)), Ca(2+) channel blocker (10(-6) M 15 min(-1) nicardipine) and PI3 kinase inhibitor (10(-7) M per wortmannin). An inositol 1,4,5-trisphosphate (IP3) receptor blocker (2-aminoethyl diphenyl borate; 10(-4) M 15 min(-1)) also blocked the inhibitory effect of the ETB receptor on Na(+)-K(+)ATPase activity (control=0.39+/-0.06, BQ3020=0.25+/-0.01, 2-APB=0.35+/-0.05, BQ3020+ 2-APB=0.35+/-0.06, n=4, P<0.01). The calcium channel agonist (BAY-K8644; 10(-6) M 15 min(-1)) inhibited Na(+)-K(+) ATPase activity, an effect that was blocked by a phosphatidylinositol-3 kinase inhibitor (10(-7) M 15 min(-1) wortmannin). In rat RPT cells, activation of the ETB receptor inhibits Na(+)-K(+) ATPase activity by facilitating extracellular Ca(2+) entry and Ca(2+) release from endoplasmic reticulum.

Indexed as

AnimalsCalciumCalcium SignalingCell LineEndoplasmic ReticulumEndothelinsEnzyme InhibitorsHumansInosine TriphosphateKidney Tubules, ProximalPeptide FragmentsPhosphatidylinositol 3-KinasesRatsRats, Inbred WKYReceptor, Endothelin BSecond Messenger SystemsBQ 3020CalciumEndothelinsEnzyme InhibitorsInosine TriphosphatePeptide FragmentsPhosphatidylinositol 3-KinasesReceptor, Endothelin BSodium-Potassium-Exchanging ATPase

Identifiers

PMID19662022
PMCPMC2879332
OpenAlexW2054782901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.